Who We Are

We deliver on our commitment to providing quality healthcare services and products through our three business lines: Hospitals, Polyclinics, and Diagnostics. Our well-established network allows a seamless patient treatment pathway from local doctors to multi-profile hospitals.

Our hospitals business is the largest healthcare market participant in Georgia accounting for around 14% of the country’s total hospital bed capacity as of 31 December 2023. The business operates 34 healthcare facilities in Tbilisi and major regional cities and provides secondary or tertiary-level outpatient and inpatient diagnostic, surgical, and treatment services.

To improve efficiency and seize emerging opportunities stemming from new Government regulations introduced in 2023 as detailed below, our healthcare business underwent a strategic restructuring in December 2023. This restructuring resulted in the split of the hospital business into two distinct segments: “Large and Specialty Hospitals” (comprising 7 healthcare facilities under the name Vian) and “Regional and Community Hospitals” (comprising 27 healthcare facilities under the name Georgian Clinics). The Regional and Community Hospitals now include the community clinics that were previously managed under the clinics and diagnostics business. The transition for our patients was seamless, and business operations remained uninterrupted.

Our clinic's business currently comprises two segments: 16 polyclinics and one diagnostic center. Polyclinics are located in Tbilisi and major regional cities and provide basic and full-scale outpatient diagnostic and treatment services. The business is the leader in the outpatient market with a 25% market share by number of registered patients.

The diagnostics business was launched in 2018 by opening the largest laboratory in the entire Caucasus region – “Mega Lab”. The multi-disciplinary laboratory, equipped with the latest infrastructure and state-of-the-art technology, covers 7,500 square meters. In addition to basic laboratory tests, Mega Lab offers complex tests for oncology and molecular labs, some of which have never been available in Georgia and for which blood samples used to be sent abroad. In July 2022, Mega Lab received the Joint Commission International (“JCI”) accreditation. JCI, the highest healthcare accreditation body in the US, ensures the correct management of clinical processes. Its goal is to continuously improve the quality and safety of patient care. Mega Lab is the first laboratory in the Caucasus region with JCI accreditation and 38th worldwide.